Agilent Technologies (A) vs. Biolase (BIOL) Head to Head Analysis

Agilent Technologies (NYSE: A) and Biolase (NASDAQ:BIOL) are both computer and technology companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, earnings, valuation, institutional ownership, dividends and profitability.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for Agilent Technologies and Biolase, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Agilent Technologies 0 2 11 0 2.85
Biolase 0 0 1 0 3.00

Agilent Technologies presently has a consensus target price of $64.21, indicating a potential upside of 4.83%. Biolase has a consensus target price of $2.50, indicating a potential upside of 316.67%. Given Biolase’s stronger consensus rating and higher possible upside, analysts clearly believe Biolase is more favorable than Agilent Technologies.


This table compares Agilent Technologies and Biolase’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Agilent Technologies 14.36% 16.95% 9.30%
Biolase -31.64% -64.44% -35.66%

Risk and Volatility

Agilent Technologies has a beta of 1.3, indicating that its stock price is 30% more volatile than the S&P 500. Comparatively, Biolase has a beta of 2.19, indicating that its stock price is 119% more volatile than the S&P 500.


Agilent Technologies pays an annual dividend of $0.53 per share and has a dividend yield of 0.9%. Biolase does not pay a dividend. Agilent Technologies pays out 27.3% of its earnings in the form of a dividend.

Institutional and Insider Ownership

37.6% of Biolase shares are owned by institutional investors. 7.1% of Biolase shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Earnings & Valuation

This table compares Agilent Technologies and Biolase’s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio EBITDA Earnings Per Share Price/Earnings Ratio
Agilent Technologies $4.39 billion 4.49 $1.05 billion $1.94 31.57
Biolase $50.48 million 0.90 -$14.68 million ($0.32) -1.88

Agilent Technologies has higher revenue and earnings than Biolase. Biolase is trading at a lower price-to-earnings ratio than Agilent Technologies, indicating that it is currently the more affordable of the two stocks.


Agilent Technologies beats Biolase on 9 of the 15 factors compared between the two stocks.

About Agilent Technologies

Agilent Technologies, Inc. provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business. Its life sciences and applied markets business segment offers instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products, as well as enable customers in the clinical and life sciences research areas to interrogate samples at the molecular level. Its diagnostics and genomics business segment includes the reagent partnership, pathology, companion diagnostics, genomics and the nucleic acid solutions businesses. Its Agilent CrossLab business segment spans the entire lab with its consumables and services portfolio.

About Biolase

BIOLASE, Inc. (BIOLASE) is a medical device company that develops, manufactures, markets and sells laser systems in dentistry and medicine. The Company markets, sells, and distributes dental imaging equipment, including cone beam digital x-rays and computer-aided design (CAD)/computer-aided manufacturing (CAM) intra-oral scanners, in-office, chair-side milling machines and three-dimensional (3-D) printers. It offers two categories of laser system products: WaterLase (all-tissue) systems and Diode (soft tissue) systems. Its brand, WaterLase, uses a combination of water and laser energy to perform procedures performed using drills, scalpels, and other traditional dental instruments for cutting soft and hard tissue. It also offers its Diode laser systems to perform soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. Its Waterlase and Diode systems use disposable laser tips of differing sizes and shapes depending on the procedures being performed.

Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with's FREE daily email newsletter.

Latest News

Leave a Reply